Huang and Zhang [49] identified FDFT1 as a potential biomarker associated with ferroptosis in kidney cancer (KIRC), finding that FDFT1 upregulation inhibited cell proliferation, migration, and invasion, with potential antitumor effects occurring via the AKT signaling pathway. The gene discussed is FDFT1; the disease is kidney cancer.